Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Hashimoto

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Plos One|April 3, 2009
Fascin-1 promoter activity is regulated by CREB and the aryl hydrocarbon receptor in human carcinoma cellsYosuke Hashimoto, David W Loftis, Josephine C Adams
Fluids and Barriers of the CNS|March 28, 2023
The CLDN5 gene at the blood-brain barrier in health and diseaseYosuke Hashimoto, Chris Greene, Arnold Munnich, et al.
The Journal of Pathology|May 28, 2011
The roles of fascins in health and diseaseYosuke Hashimoto, Dae Joong Kim, Josephine C Adams
Plos One|July 19, 2012
Mechanism of case processing in the brain: an fMRI studySatoru Yokoyama, Hideki Maki, Yosuke Hashimoto, et al.
Molecular Pharmaceutics|June 14, 2015
Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated ProteinYu Mima, Yosuke Hashimoto, Taro Shimizu, et al.
Oncology|November 24, 2004
The prognostic relevance of fascin expression in human gastric carcinomaYosuke Hashimoto, Yutaka Shimada, Junichiro Kawamura, et al.
Annals of the New York Academy of Sciences|April 18, 2017
Claudin-targeted drug development using anti-claudin monoclonal antibodies to treat hepatitis and cancerYosuke Hashimoto, Masayoshi Fukasawa, Hiroki Kuniyasu, et al.
Chemical & Pharmaceutical Bulletin|April 3, 2015
Synthesis and evaluation of fatty acid amides on the N-oleoylethanolamide-like activation of peroxisome proliferator activated receptor αKoichi Takao, Kaori Noguchi, Yosuke Hashimoto, et al.
Biological & Pharmaceutical Bulletin|October 4, 2021
Claudin-5: A Pharmacological Target to Modify the Permeability of the Blood-Brain BarrierYosuke Hashimoto, Matthew Campbell, Keisuke Tachibana, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 18, 2008
Inhibitory effects of 2,6-di-O-methyl-alpha-cyclodextrin on poly I:C signaling in macrophagesKeiichi Motoyama, Yosuke Hashimoto, Fumitoshi Hirayama, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Plos One|April 3, 2009
Fascin-1 promoter activity is regulated by CREB and the aryl hydrocarbon receptor in human carcinoma cellsYosuke Hashimoto, David W Loftis, Josephine C Adams
Fluids and Barriers of the CNS|March 28, 2023
The CLDN5 gene at the blood-brain barrier in health and diseaseYosuke Hashimoto, Chris Greene, Arnold Munnich, et al.
The Journal of Pathology|May 28, 2011
The roles of fascins in health and diseaseYosuke Hashimoto, Dae Joong Kim, Josephine C Adams
Plos One|July 19, 2012
Mechanism of case processing in the brain: an fMRI studySatoru Yokoyama, Hideki Maki, Yosuke Hashimoto, et al.
Molecular Pharmaceutics|June 14, 2015
Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated ProteinYu Mima, Yosuke Hashimoto, Taro Shimizu, et al.
Oncology|November 24, 2004
The prognostic relevance of fascin expression in human gastric carcinomaYosuke Hashimoto, Yutaka Shimada, Junichiro Kawamura, et al.
Annals of the New York Academy of Sciences|April 18, 2017
Claudin-targeted drug development using anti-claudin monoclonal antibodies to treat hepatitis and cancerYosuke Hashimoto, Masayoshi Fukasawa, Hiroki Kuniyasu, et al.
Chemical & Pharmaceutical Bulletin|April 3, 2015
Synthesis and evaluation of fatty acid amides on the N-oleoylethanolamide-like activation of peroxisome proliferator activated receptor αKoichi Takao, Kaori Noguchi, Yosuke Hashimoto, et al.
Biological & Pharmaceutical Bulletin|October 4, 2021
Claudin-5: A Pharmacological Target to Modify the Permeability of the Blood-Brain BarrierYosuke Hashimoto, Matthew Campbell, Keisuke Tachibana, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 18, 2008
Inhibitory effects of 2,6-di-O-methyl-alpha-cyclodextrin on poly I:C signaling in macrophagesKeiichi Motoyama, Yosuke Hashimoto, Fumitoshi Hirayama, et al.
Pageof 8